Correlation Between Everus Construction and Dianthus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Everus Construction and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Everus Construction and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Everus Construction Group and Dianthus Therapeutics, you can compare the effects of market volatilities on Everus Construction and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Everus Construction with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Everus Construction and Dianthus Therapeutics.

Diversification Opportunities for Everus Construction and Dianthus Therapeutics

-0.37

Correlation Coefficient

Everus Construction  Dianthus Therapeutics

Very good diversification

The 3 months correlation between Everus and Dianthus is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Everus Construction Group and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Everus Construction is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Everus Construction Group are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Everus Construction i.e., Everus Construction and Dianthus Therapeutics go up and down completely randomly.

Pair Corralation between Everus Construction and Dianthus Therapeutics

Considering the 90-day investment horizon Everus Construction Group is expected to generate 0.73 times more return on investment than Dianthus Therapeutics. However, Everus Construction Group is 1.36 times less risky than Dianthus Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Dianthus Therapeutics is currently generating about 0.06 per unit of risk. If you would invest  4,900  in Everus Construction Group on October 3, 2024 and sell it today you would earn a total of  1,675  from holding Everus Construction Group or generate 34.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	18.47%
Values	Daily Returns

Everus Construction Group  vs.  Dianthus Therapeutics

Everus Construction

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Everus Construction Group are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly sluggish fundamental indicators, Everus Construction reported solid returns over the last few months and may actually be approaching a breakup point.

Dianthus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Everus Construction and Dianthus Therapeutics

The main advantage of trading using opposite Everus Construction and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Everus Construction position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.

The idea behind Everus Construction Group and Dianthus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.